DAFNA Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Sell |
|
|||||
|
2025
Q1 | $4.19M | Sell |
|
|||||
|
2024
Q4 | $5.02M | Hold |
|
|||||
|
2024
Q3 | $5.07M | Sell |
|
|||||
|
2024
Q2 | $4.35M | Sell |
|
|||||
|
2024
Q1 | $3.6M | Hold |
|
|||||
|
2023
Q4 | $4.25M | Buy |
|
|||||
|
2023
Q3 | $4.62M | Buy |
|
|||||
|
2023
Q2 | $4.01M | Buy |
|
|||||
|
2023
Q1 | $4.6M | Buy |
|
|||||
|
2022
Q4 | $2.88M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.57M | Buy |
|
|||||
|
2020
Q2 | $3.54M | Buy |
|
|||||
|
2020
Q1 | $958K | Sell |
|
|||||
|
2019
Q4 | $1.77M | Buy |
|
|||||
|
2019
Q3 | $1.39M | Buy |
|
|||||
|
2019
Q2 | $1.56M | Sell |
|
|||||
|
2019
Q1 | $4.06M | Buy |
|
|||||
|
2018
Q4 | $3.75M | Sell |
|
|||||
|
2018
Q3 | $4.97M | Buy |
|
|||||
|
2018
Q2 | $3.46M | Sell |
|
|||||
|
2018
Q1 | $4.65M | Sell |
|
|||||
|
2017
Q4 | $5.86M | Hold |
|
|||||
|
2017
Q3 | $6.25M | Buy |
|
|||||
|
2017
Q2 | $3.29M | Buy |
|
|||||
|
2017
Q1 | $4.54M | Buy |
|
|||||
|
2016
Q4 | $417K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $423K | Sell |
|
|||||
|
2015
Q4 | $2.64M | Sell |
|
|||||
|
2015
Q3 | $2.95M | Buy |
|
|||||
|
2015
Q2 | $3.31M | Buy |
|
|||||
|
2015
Q1 | $1.5M | Hold |
|
|||||
|
2014
Q4 | $2.03M | Buy |
|
|||||
|
2014
Q3 | $747K | Buy |
|